Semaglutide vs Liraglutide
Research & educational use only. This content is not medical advice. Consult a qualified healthcare professional before using any peptide compound.
Semaglutide and Liraglutide are both glp1 peptides that come up together constantly. This is a side-by-side comparison on the data that actually matters — evidence tier, FDA status, human trials, and how to source each safely — not hype. It is for research and educational purposes only.
Semaglutide vs Liraglutide: side-by-side
| Semaglutide | Liraglutide | |
|---|---|---|
| Evidence tier | Tier 1 | Tier 1 |
| FDA status | FDA Approved | FDA Approved |
| Human RCTs | 10 | 9 |
| Subjects enrolled | 20,000 | 15,000 |
| Animal studies | 12 | 12 |
| Category | glp1 | glp1 |
| Half-life | Approximately 7 days, enabling once-weekly administration. | Approximately 13 hours, supporting once-daily dosing. |
| Community logs | 1 | 0 |
Key differences
Both Semaglutide and Liraglutide sit at the same evidence tier (Tier 1), so neither has a clear edge in how strong its human data is. Both are FDA approved for specific indications.
Semaglutide has 10 human trials on record (20,000 subjects) versus Liraglutide's 9 (15,000 subjects). Evidence tiers are a shorthand for how strong that human data is — see our guide to understanding peptide evidence tiers for how to weigh them.
What is Semaglutide?
Semaglutide is a GLP-1 receptor agonist approved by the FDA (as Ozempic and Rybelsus for type 2 diabetes, and Wegovy for chronic weight management). It is supported by large phase 3 randomized controlled trials, including cardiovascular outcome data. It is a prescription medication; gray-market research-chemical… Full Semaglutide breakdown →
What is Liraglutide?
Liraglutide is a GLP-1 receptor agonist approved by the FDA for type 2 diabetes (as Victoza) and for chronic weight management (as Saxenda). It is supported by large phase 3 randomized controlled trials, including the LEADER cardiovascular outcomes trial and the SCALE obesity program. It is a once-daily injectable… Full Liraglutide breakdown →
Where to buy Semaglutide or Liraglutide safely
Both are sold by research-chemical suppliers, not pharmacies, so the source matters as much as the compound. Before buying either, vet sellers on third-party lab testing and enforcement history in the ranked directory of trusted peptide sellers — or jump straight to vetted sources for Semaglutide or Liraglutide. PeptidesHub does not sell either compound.
Frequently asked questions
Semaglutide and Liraglutide are both glp1 peptides. Both Semaglutide and Liraglutide sit at the same evidence tier (Tier 1), so neither has a clear edge in how strong its human data is. Both are FDA approved for specific indications. See each compound's full evidence breakdown for the underlying studies.